Over-expression of cofilin-1 and phosphoglycerate kinase 1 in astrocytomas involved in pathogenesis of radioresistance

CNS Neuroscience and Therapeutics

Volumn 18, Issue 9, 2012, Pages 729-736

  Yan, Hua ^a   Yang, Kun ^a   Xiao, Hong ^a   Zou, Yuan Jie ^a   Zhang, Wen Bin ^a   Liu, Hong Yi ^a  

^a THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Astrocytomas; Prognosis; Proteomics; Radioresistance; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; COFILIN 1; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; COFILIN 1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHOGLYCERATE KINASE; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865804556     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00353.x     Document Type: Article

References (41)

1. Mahaley MS, Mettlin C, Natarajan N, Laws ER, Peace BB National survey of patterns of care for brain-tumour patients. J Neurosurg 1989;71: 826-836.
2. Bello L, Giussani C, Carrabba G, et al. Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors. Clin Cancer Res 2002;8: 3539-3548.
3. Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 2005;65: 7674-7681.
4. Iwadate Y, Sakaida T, Hiwasa T, et al. Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 2004;64: 2496-2501.
5. Boudreau CR, Yang I, Liau LM Gliomas: Advances in molecular analysis and characterization. Surg Neurol 2005;64: 286-294.
6. Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 1996;13: 19-50.
7. Whittle IR, Short DM, Deighton RF, Kerr LE, Smith C, McCulloch J Proteomic analysis of gliomas. Br J Neurosurg 2007;21: 576-582.
8. Chakravarti A, Delaney MA, Noll E, et al. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 2001;7: 2387-2395.
9. Chumbalkar V, Sawaya R, Bogler O Proteomics: The new frontier also for brain tumor research. Curr Probl Cancer 2008;32: 143-154.
10. Hajkova D, Imanishi Y, Palamalai V, et al. Proteomic changes in the photoreceptor outer segment upon intense light exposure. J Proteom Res 2010;9: 1173-1181.
11. Hwang TL, Liang Y, Chien KY, Yu JS Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics 2006;6: 2259-2272.
12. Chen G, Gharib TG, Wang H, et al. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003;100: 13537-13542.
13. Fantin VR, St-Pierre J, Leder P Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9: 425-434.
14. Zieker D, Königsrainer I, Tritschler I, et al. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer 2010;126: 1513-1520.
15. Wang JH, Wang JC, Dai JL, et al. A Glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 2007;67: 149-159.
16. Romanuik TL, Ueda T, Le N, et al. Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol 2009;175: 2264-2276.
17. Brizel DM, Dodge RK, Clough RW, Dewhirst MW Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53: 113-117.
18. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48: 149-156.
19. Knocke TH, Weitmann HD, Feldmann HJ, Selzer E, Potter R Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 1999;53: 99-104.
20. Nordsmarka M, Overgaard J A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000;57: 39-43.
21. Duan Z, Lamendola DE, Yusuf RZ, Penson RT, Preffer FI, Seiden MV Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 2002;22: 1933-1941.
22. Vishwanatha JK, Jindal HK, Davis RG The role of primer recognition proteins in DNA replication: Association with nuclear matrix in HeLa cells. J Cell Sci 1992;101: 25-34.
23. Popanda O, Fox G, Thielman HW Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim Biophys Acta 1998;1397: 102-117.
24. Ronai Z Glycolytic enzymes as DNA binding proteins. Int J Biochem 1993;25: 1073-1076.
25. Bernstein BW, Bamburg JR ADF/Cofilin: A functional node in cell biology. Trends Cell Biol 2010;20: 187-195.
26. Huang TY, Minamide LS, Bamburg JR, Bokoch GM Chronophin mediates an ATP-sensing mechanism for cofilin dephosphorylation and neuronal cofilin-actin rod formation. Dev Cell 2008;15: 691-703.
27. Pavlov D, Muhlrad A, Cooper J, Wear M, Reisler E Actin Filament Severing by Cofilin. J Mol Biol 2007;365: 1350-1358.
28. Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-Actin depolymerization in mammalian nonmuscle cells. Mol Biol Cell 2005;16: 649-664.
29. Vartiainen MK, Mustonen T, Mattila PK, et al. The three mouse actin-depolymerizing factor/cofilins evolved to fulfill cell-type-specific requirements for actin dynamics. Mol Biol Cell 2002;13: 183-194.
30. Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS Cofilin promotes actin polymerization and defines the direction of cell motility. Science 2004;304: 743-746.
31. Chan AY, Bailly M, Zebda N, Segall JE, Condeelis JS Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion. J Cell Biol 2000;148: 531-542.
32. Kuhn TB, Meberg PJ, Brown MD, et al. Regulating actin dynamics in neuronal growth cones by ADF/cofilin and rho family GTPases. J Neurobiol 2000;44: 126-144.
33. Yap CT, Simpson TI, Pratt T, et al. The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton 2005;60: 153-165.
34. Yana B, Yapb CT, Wanga S, et al. Cofilin immunolabelling correlates with depth of invasion in gastrointestinal endocrine cell tumors. Acta Histochem 2010;112: 101-106.
35. Kaczarek E, Zapf S, Bouterfa H, et al. Dissecting glioma invasion: Interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype. Int J Dev Neurosci 1999;17: 625-641.
36. Nishimura S, Tsuda H, Kataoka F, et al. Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy. Hum Pathol 2011;42: 516-521.
37. Gunersen JM, Spirkoska V, Smith PE, et al. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 2000;32: 146-154.
38. Klemke M, Wabnitz GH, Funke F, et al. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 2008;29: 404-413.
39. Olive PL, MacPhail SH Radiation-induced DNA unwinding is influenced by cell shape and trypsin. Radiat Res 1992;130: 241-248.
40. Minamide LS, Striegl AM, Boyle JA, et al. Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function. Nat Cell Biol 2000;2: 628-636.
41. Odreman F, Vindigni M, Gonzales ML, et al. Proteomic studies on low- and high-grade human brain astrocytomas. J Proteome Res 2005;4: 698-708.